text.skipToContent text.skipToNavigation
  • /medias/default-supplier-banner-2.jpg?context=bWFzdGVyfHJvb3R8MzAyODU5fGltYWdlL2pwZWd8YUdKbEwyZzVOUzg1TnpNM016VTFPVFV5TVRVNEwyUmxabUYxYkhRdGMzVndjR3hwWlhJdFltRnVibVZ5TFRJdWFuQm58YTAxNGVjODAzZjhkMjUxOWI2Nzk3YjhiZDkwN2ZlMzI1YzdmYjViYjdlYjc5YmRiOTA4MWVhYTczZDk1MTBjOQ
Applied FiltersClear all

Country

Switzerland (1)

Category

Pharmaceutical Ingredients (1)

Sub Category

API (1)

Application

Antineoplastic (1)

Supplier

DKSH (1)

Physical Form

Solid (1)

Function

Mantle cell lymphoma (1)

Multiple myeloma (1)

Certification

DMF (1)

Sustainable

false (1)

Close Filter

DKSH

We have found 1 items.

Filter
Applied FiltersClear all

Category

Pharmaceutical Ingredients (1)

Sub Category

API (1)

Application

Antineoplastic (1)

Physical Form

Solid (1)

Function

Mantle cell lymphoma (1)

Multiple myeloma (1)

Certification

DMF (1)

Sustainable

false (1)

Close Filter
Sample Request
Requestor's contact details
Full name
Company
Position
Telephone number
Work email address
Shipping address
Submit

Thank you. Your request has been sent.

Bortezomib

Bortezomib is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications.
Quote request
Product quantity has been updated.